X4 Pharmaceuticals (XFOR) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XFOR is expected to report earnings to fall 11.89% to -15 cents per share on March 13

X4 Pharmaceuticals XFOR Stock Earnings Reports

Q4'24

Est.

$-0.16

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.46

Q1'24

Missed

by $0.12

Q4'23

Beat

by $0.05

The last earnings report on November 13 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 2.51M shares outstanding, the current market capitalization sits at 109.34M.

View a ticker or compare two or three

Compare

XFOR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XFOR
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biotechnology company which engages in developing human antibodies for treating infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

61 North Beacon Street

Phone

+1 857 529-8300

Employees

Web

https://www.x4pharma.com